All Stories

  1. A recessive ataxia diagnosis algorithm for the next generation sequencing era
  2. Body Mass Index Decline Is Related to Spinocerebellar Ataxia Disease Progression
  3. Standardized Assessment of Hereditary Ataxia Patients in Clinical Studies
  4. Deferiprone in Friedreich ataxia: A 6-Month randomized controlled trial
  5. Cerebellar and Afferent Ataxias
  6. A new locus for familial temporal lobe epilepsy on chromosome 3q
  7. Deferiprone for the treatment of Friedreich's ataxia
  8. Increasing frataxin gene expression with histone deacetylase inhibitors as a therapeutic approach for Friedreich's ataxia
  9. Pediatric epilepsy genetics
  10. Treatment of Friedreich's ataxia
  11. Antioxidants and other pharmacological treatments for Friedreich ataxia
  12. Friedreich ataxia
  13. Genetics of Epilepsy
  14. 105 Left ventricular twist in patients with Friedreich Ataxia and normal left ventricular ejection fraction and mass
  15. PGC-1alpha Down-Regulation Affects the Antioxidant Response in Friedreich's Ataxia
  16. Development of histone deacetylase inhibitors as therapeutics for neurological disease
  17. Antioxidants and other pharmacological treatments for Friedreich ataxia
  18. Antioxidants and other pharmacological treatments for Friedreich ataxia
  19. Blood–Brain Barrier Promotes Differentiation of Human Fetal Neural Precursor Cells
  20. Introduction
  21. Friedreich ataxia: The clinical picture
  22. The pathogenesis of Friedreich ataxia and the structure and function of frataxin
  23. Friedreich Ataxia
  24. Author response to “Reply to Drug Insight: antioxidant therapy in inherited ataxias”
  25. Drug Insight: antioxidant therapy in inherited ataxias
  26. Mutations causing Friedreich ataxia
  27. The Neurological Presentation of Ceruloplasmin Gene Mutations
  28. Effects of anti–glutamic acid decarboxylase antibodies associated with neurological diseases
  29. Chapter 7 Friedreich Ataxia
  30. Friedreich's Ataxia
  31. Effects of levetiracetam on the production of nitric oxide
  32. Animal Models of Friedreich Ataxia
  33. Striking intrafamilial phenotypic variability and spastic paraplegia in the presence of similar homozygous expansions of the FRDA1 gene
  34. Frataxin overexpressing mice
  35. Interaction between repetitive stimulation of the sciatic nerve and functional ablation of cerebellar nucleus interpositus in the rat
  36. Myorhythmia associated with Hodgkin?s lymphoma
  37. Friedreich ataxia
  38. Bilateral High-Frequency Synchronous Discharges
  39. Friedreich Ataxia
  40. Frataxin deficiency and mitochondrial dysfunction
  41. Iron Metabolism and Mitochondrial Abnormalities in Friedreich Ataxia
  42. Response to Commentary 1: Abnormal Mitochondrial Iron Metabolism in Friedreich Ataxia
  43. Frataxin knockin mouse
  44. Manganese superoxide dismutase induction by iron is impaired in Friedreich ataxia cells
  45. Friedreich's ataxia
  46. The Cerebellum and its Disorders
  47. Molecular basis of Friedreich ataxia
  48. Molecular Pathogenesis of Friedreich Ataxia
  49. Sticky DNA
  50. Friedreich's Ataxia: Clinical Aspects and Pathogenesis
  51. A missense mutation (W155R) in an American patient with Friedreich Ataxia
  52. Heteroduplexes may confuse the interpretation of PCR-based molecular tests for the Friedreich ataxia GAA triplet repeat
  53. Heteroduplexes may confuse the interpretation of PCR-based molecular tests for the Friedreich ataxia GAA triplet repeat
  54. Molecular genetics and pathogenesis of Friedreich ataxia
  55. Prenatal diagnosis of Friedreich ataxia
  56. Prenatal diagnosis of Friedreich ataxia
  57. 2 Molecular Genetics of the Hereditary Ataxias
  58. Friedreich ataxia: clinical and genetic aspects
  59. Frataxin Shows Developmentally Regulated Tissue-Specific Expression in the Mouse Embryo
  60. Mapping of the congenital generalized hypertrichosis locus to chromosome Xq24–q27.1
  61. The myelin basic protein gene is not a major susceptibility locus for multiple sclerosis in Italian patients
  62. A rapid method to isolate (GT)n repeats from yeast artificial chromosomes
  63. Regional localization by in situ hybridization of a human chromosome 9 marker tightly linked to the Friedreich's ataxia locus
  64. A TaqI RFLP in the locus D9S29 on human chromosome 9
  65. A Pvu II RFLP in the human ADH3 gene
  66. An anonymous DNA probe (LAMP 92) detects a Pvu II polymorphism on human chromosome 9 [D9S29]
  67. Single stranded DNA binding proteins derive from hnRNP proteins by proteolysis in mammalian cells
  68. Mammalian single-stranded DNA binding proteins and heterogeneous nuclear RNA proteins have common antigenic determinants
  69. Friedreich Ataxia
  70. Friedreich Ataxia: Detection of GAA Repeat Expansions and Frataxin Point Mutations
  71. Foreword by Sid Gilman